Biological Activity at the Tick Feeding Interface
=================================================

Biological function is central to the understanding of life and organismal biology. The context that function confers is exemplified in the frustration felt when a gene or protein of interest can only be annotated as a hypothetical protein with unknown function. Conversely, the ease of annotation by homology has made genome sequencing and assignment of function to orthologs an almost mundane task ([@B79]). Even so, biochemical characterization remains central to the elucidation and confirmation of new function and the understanding of functional mechanism. From a biochemical reductionist perspective, biological function may be explained within a structural mechanistic context as the action of a gene, surface, motif or residue that result in a chemical reaction, activation or inhibition of an enzyme or receptor, or even a physiological process such as blood clotting or platelet aggregation. The current review considers biological function at the tick--host interface from this reductionist perspective ([@B61]). Even so, it was recently suggested that before or during evolution of new function by gene duplicates, and before negative selection maintain the adaptive advantage conferred by such new functions, new duplicates may exist in a state of undefined or non-optimized function, where protein expression is maintained while functional space is explored by random mutation: the playground hypothesis of neutral evolution ([@B146]). There is also an increasing recognition that most proteins may exhibit "promiscuous activity," i.e., irrelevant secondary activities ([@B39], [@B40]). In addition, given the possibility that a biochemical assay may yield results for a broad class of proteins with diverse functions, or even results without biological meaning, it raise the question whether any particular measured function is relevant within a biological or physiological context. The current review therefore also considers functional relevance at the tick--host interface from this perspective.

[@B218], after reading Haycraft's work on the anti-clotting effects of the oral secretions from leeches ([@B86]), made the first prescient deduction that all hematophagous organisms must secrete components that interfere or regulate host defenses, such as the hemostatic system. He tested this by showing that crude whole body tick extracts led to *in vitro* inhibition of blood clotting and that injecting this extract into various animals led to prolongation of blood coagulation *in vivo*. He also injected what may very well be the first fractionation of tick proteins to show that this purified preparation retained its inhibitory properties. Sabbatani's deduction has been confirmed by extensive research into tick--host interactions that established a veritable pharmacopeia of bioactive components secreted by ticks during feeding (reviewed in [@B154]; [@B71]; [@B145]). However, a question that must have plagued him and remains relevant today, is whether *in vitro* and even *in vivo* observations can be causally linked with biological relevant activity at the feeding site, i.e., do what we measure in a test tube really function as a modulator of host defenses during feeding? The observation that ticks can cause paralysis in a host (Hovell, 1824 cited in [@B228]) and the presence of salivary glands in ticks ([@B251]; [@B130]; [@B88]), must have suggested that ticks can secrete substances into the host. Phenotypic changes in the host such as itching or ecchymosis after tick bite also suggested that ticks secrete substances into the host ([@B177]). Secretion and therefore presence would imply activity at the feeding site. However, the presence of toxic and anti-hemostatic molecules in tick eggs, but not salivary glands or saliva, showed that measurement of biological activity in crude extracts does not necessarily imply function at the tick--host interface ([@B90]; [@B47]; [@B210], [@B211]; [@B81]; [@B171]; [@B250]; [@B157]). This implication was recognized soon after Sabbatani's seminal study, when researchers extended his observations by proving that anti-hemostatic and toxic activities were present in salivary glands of ticks ([@B176]; [@B41]; [@B214]; [@B90]). It would take a number of years before anti-hemostatic and toxic activity could be showed to be secreted in tick saliva itself. This had to await chemical means, such as pilocarpine, or mechanical means, such as infra-red light, to stimulate salivation in order to obtain adequate quantities of salivary secretion for demonstration of biological activity ([@B94]; [@B239]; [@B172], [@B170]; [@B56]; [@B208], [@B202]; [@B209]; [@B207]). However, as [@B239] indicated: salivary secretions obtained with exogenous stimulants should be treated with caution, since it is unclear whether such secretions represent the total saliva complement or even represent saliva, since cement is not found in such secretions. This may be a pertinent observation since cement may readily form during feeding on artificial membranes ([@B124]), arguing that induced salivation is not entirely the same as salivation during actual feeding.

Confirmation of secretion during feeding remains a crucial component of validation of biological relevance ([@B127]). This may be achieved to various extents, by direct determination of the presence of a specific activity or molecule in saliva, or detection of host-derived antibodies generated against components secreted during feeding ([@B207]; [@B180]; [@B166]). Detection in the salivary glands or salivary gland extract (SGE) may be used as an indication of secretion, especially if a secretory peptide signal is present in the immature protein sequence ([@B173]). The latter have been extensively used to identify potential secretory components during transcriptome analysis (reviewed in [@B145]). However, secretion of some proteins without canonical signal peptides and non-salivary gland derived proteins via apocrine or alternative secretion has complicated the distinction of true and false positive secretory components ([@B166]; [@B55]; [@B181]; [@B242], [@B241]), thereby also obscuring deduction of biological relevance ([@B145]). Not all salivary gland proteins with signal peptides are necessarily secreted during feeding ([@B173]), nor are all secretory proteins secreted at the same time, such as the case for hard ticks, that show differential expression over the course of several days of feeding ([@B161]; [@B183]; [@B253]; [@B45], [@B46]; [@B116]; [@B188]). Transcriptome and proteome data also shows a weak correlation ([@B227]). While this may be ascribed to technical limitations in the proteomic and transcriptomic analysis of complex samples from non-model organisms, it further complicates the assessment of the final relevant concentration of protein present during feeding.

The Equilibrium State and Functional Correlates
-----------------------------------------------

Le Chatelier's principle states that an equilibrium system will tend to counteract changes to the system to maintain its equilibrium. In biological systems this is overcome by enzymes that create intermediate states to catalyze non-reversible chemical reactions. In the case of receptor-ligand or protein-inhibitor binding, the affinity of the receptor for the ligand and the relative receptor and ligand concentrations determines the bound state at equilibrium ([Figure 1](#F1){ref-type="fig"}). The affinity between molecules is expressed as the equilibrium dissociation constant (*K*~D~) that range for most biological systems from the fM to mM range ([@B231]). The *K*~D~ is the ligand concentration at which 50% of the receptor is occupied at equilibrium ([Figure 1](#F1){ref-type="fig"}). At a ligand concentration 10-fold the *K*~D~, a receptor would be 91% saturated and above this concentration almost all of the receptor will be occupied. However, at a ligand concentration 10-fold less than the *K*~D~, only 9% of the receptor would be occupied by the ligand and below this concentration essentially no binding occurs. At concentrations of the ligand that is equal to its *K*~D~, only 50% of the receptor will be occupied if the stoichiometry of binding is 1:1. The *K*~D~ is therefore also considered to reflect a physiological relevant concentration ([@B229]). Concentrations of salivary proteins at the feeding site would therefore be physiologically relevant only at concentrations equal or exceeding their affinities for their targets by 10-fold or more if 50--100% receptor occupancy is necessary for effective inhibition. The *K*~i~ (inhibitor constant) is determined for inhibitors of enzyme active sites and reflect the concentration necessary to reduce enzyme activity by half. It is generally used in the characterization of inhibitors using enzyme kinetics and depends on both enzyme affinity for substrate and inhibitor affinity for enzyme. Even so, it is similar to the *K*~D~ and should produce similar values when enzyme activity is measured at physiological concentrations. Another measurement analogous to the *K*~D~ is the IC~50~ value of an inhibitor. The IC~50~ value (half-maximal inhibitory concentration) is the concentration at which 50% inhibition of function is observed. This is generally determined for complex processes such as inhibition of platelet aggregation, blood clotting, or cell migration. This value would ultimately depend on the concentration of receptor or number of cells used in an assay, but would be close to the *K*~D~ if physiologically relevant receptor or cell concentrations were used. Another measure that may indicate physiological relevance is the stoichiometric inhibition ratio (SI). This ratio indicate physiological relevance when an inhibitor interact with an enzyme or receptor close to equimolar ratios, since this imply high affinity, so that for example an SI = 2 imply saturation of receptor at 2*K*~D~. This may be seen for suicide inhibitors that bind irreversible to the enzyme active site. In enzyme kinetics the *K*~m~ (Michaelis constant) is the substrate concentration that allows an enzyme to attain half *V*~max~. *V*~max~ is the maximum reaction rate of the enzyme when saturated with substrate. While the *K*~m~ is dependent on rate constants rather than ligand concentration it is also an indication of affinity and provide an estimate of relevant concentrations of substrates where an enzyme will function. For example, if a given agonist functions at concentrations 10-fold lower than the *K*~m~, the enzyme will not be able to effectively remove this agonist from the system and neutralize its effect. The *K*~D~, *K*~i~, IC~50~, SI, and *K*~m~ are therefore all useful to assess the physiological relevance of any biological activity. The reader is referred to [@B126] for a general treatment of protein-ligand affinity.

![The universal binding isotherm express the relationship between receptor occupation by a ligand (fraction bound) and the equilibrium dissociation constant (*K*~D~) with regard to the concentration of ligand present for a 1:1 interaction at equilibrium. At a ligand concentration that equals the *K*~D~ (1*K*~D~), 50% of the receptor will be occupied. At a ligand concentration 10-fold more than the *K*~D~ (10*K*~D~), 91% of the receptor will be occupied. Above this concentration a given ligand should be physiologically significant. At a ligand concentration 10-fold less than the *K*~D~ (*K*~D~/10) only 9% of the receptor will be occupied. Below this concentration physiological significance should be suspect. Between 10*K*~D~ and *K*~D~/10 a gray area exist where physiological significance will depend on environmental factors.](fphys-10-00530-g001){#F1}

Another measure of potential functional activity is the amount of salivary gland equivalents that may have a measurable impact or functionality. For example, ∼0.125 salivary gland equivalents from the tick *Ornithodoros kalahariensis* (previously *Ornithodoros savignyi*, [@B15]), was able to increase clotting time for the APTT test by 400%, 0.4% of a salivary gland could inhibit fXa ∼100 and 0.07% could inhibit thrombin by ∼100% ([@B76]). As such, any function that may be measured from the equivalent of 2 salivary glands (∼1 tick) or less that has an appreciable effect on some function may indicate the presence of relevant functionality. Even so, if characterizing crude extracts, it should be considered that the sum of multiple functions may be measured and that individual activities may be much less.

Whether a molecule will have relevant biological activity at the feeding site depends on their affinities for their respective ligands or receptors and whether they are secreted at relevant biological concentrations. In terms of chemical equilibrium, this implies that inhibitors or kratagonists (dealt with below) needs to be present at the feeding site at higher concentrations than the *K*~D~ for their respective receptors or ligands. At concentrations below the *K*~D~ little or no binding will occur and inhibitors may not be effective or physiologically relevant. In addition to satisfying concentration requirements, competition between host-derived substrates, ligands or receptors and tick-derived inhibitors, enzymes or scavengers for activating biomolecules will determine whether potential host-modulatory molecules may be biologically significant. This is essentially determined by the comparative affinities of host vs. tick-derived receptor-ligand interaction. Again, the biological relevance of host-derived agonists will be determined by their active concentrations at the feeding site. Effective concentration may also be determined by protein turnover or half-life at the feeding site. This will depend on secretion into the feeding site, concentration and sequestration at the feeding site and protein stability. In the case of secretory proteins, most have disulphide bonds that increase their stability ([@B145]), contributing toward their effective concentrations. Modulation of host defenses at the tick--host interface therefore depends on interplay between these factors, with the implication that tick-derived antagonists need to be present at higher concentrations than host-derived agonists and have higher affinities for their shared targets ([Figure 2](#F2){ref-type="fig"}).

![Parameters that influence functional relevance at the feeding site for any salivary gland protein secreted during feeding. Drawing courtesy of Ronel Pienaar.](fphys-10-00530-g002){#F2}

The Feeding Site: Effective Volume Determines Functionality
-----------------------------------------------------------

The equilibrium state is an ideal closed state and the feeding site may be considered as such. However, while the feeding site may have a defined volume approximating a closed state, the feeding site itself may be dynamic with constant changes in concentration of both host and tick proteins. Ticks ingests blood meal and salivary components, since ticks alternately salivate and ingest blood meal ([@B12]; [@B115]), thereby removing both volume and active components from the feeding site. These repetitive doses of saliva, alternating by sucking events may be considered to be independent equilibrium events and in such a case may suggest that estimates of concentration at the feeding site may be lower than described below. Tick-derived molecules may also be removed into the general systemic system of the host or the general area around the feeding site, as evidenced by the systemic effects seen during paralysis and tick toxicoses ([@B157]). Influx of blood or lymph into the feeding site may also dilute tick-derived proteins as seen in the case of edema ([@B115]). As such, while the feeding site itself has been described as a hematoma or cavity that seems self-contained, the site itself may be much more dynamic than a defined cavity of blood.

A critical question remains as to what extent the feeding site may be reduced to a biochemical reaction in a test tube, i.e., can we measure the feeding site, calculate the feeding site volume and determine the amount of saliva secreted by the tick to derive estimations of biological concentrations at the feeding site? However, the feeding site is a complex and dynamic environment that changes constantly as determined by both the tick and the host ([@B178]). For example, ticks secrete enzymes that degrade the extracellular matrix over time, increasing the feeding site volume, while host wound healing responses will tend to counteract an increase in feeding site volume ([@B264]). On the other hand, host inflammatory responses such as edema and cellular infiltration will tend to increase the feeding site volume, while hard ticks actively secrete excess blood-meal derived water back into the host, which will further contribute to feeding site volume, dilution and drainage of salivary proteins. As such, feeding site volumes have been conservatively estimated at 10--50 μl ([@B141],[@B142]). However, feeding site volume differs between larvae, nymphs and adults, whether natural or secondary hosts are parasitized and whether hosts are naïve or immune ([@B240]; [@B23],[@B24]; [@B25]). Natural hosts tend to present smaller feeding lesions, while secondary hosts can produce large lesions due to inflammatory responses ([@B23],[@B24]; [@B25]).

Protein Concentration at the Feeding Site and Functionally Suspect Proteins
---------------------------------------------------------------------------

It may be estimated what concentrations can be expected for the average secreted protein at the feeding site, by asking what the highest protein concentration may be. In this regard, the lipocalins are known to be some of the most abundant proteins synthesized in tick salivary glands ([@B139]; [@B146]). The TSGP1-4 lipocalins from the soft tick *O. kalahariensis* has been characterized in detail. They each make up ∼5% of the total soluble salivary gland protein, comprising ∼20% of the total soluble protein content ([@B149]; [@B155]). In this case the total protein that may be secreted by a tick during a feeding event comprise ∼6 μg protein with molecular masses of ∼15 kDa each. Similarly, the savignygrins (Mr ∼ 7 kDa) also make up ∼3% of the total salivary gland protein with ∼4 μg of protein secreted during a feeding event ([@B151]). In the case of the lipocalins from the soft ticks *Argas monolakensis*, the histamine binding protein AM-10 (Mr ∼ 16 kDa) comprise ∼23% of the total soluble protein ([@B142],[@B143]), and in this case equates with 4.6 μg of protein secreted during feeding. These concentrations are likely to be the highest estimates, since it is known that hard ticks secrete ∼30--300 times less protein than soft ticks in their saliva at any given feeding stage ([@B202]; [@B53]). The upper limit for any given protein in the adult tick salivary gland may thus be assumed to be ∼10 μg with a dynamic protein concentration range of 10,000-fold (1 ng--10 μg). If it is also assumed that nymphs have 10-fold and larvae 100-fold lower salivary concentrations than adults some interesting observations may be made regarding feeding site concentrations. For the purpose of the current study, the feeding site volumes were estimated from the studies of [@B23],[@B24]) with feeding cavities for larvae from 0.1 to 50 nl, nymphs from 5 to 150 nl, and adults from 10 nl to 10 μl. Using these assumptions concentration fluctuation at the feeding site can be estimated at various salivary gland protein concentrations and molecular masses of proteins. Under these assumptions the concentrations at the feeding site do not differ extensively between larvae, nymphs or adults, even though feeding site volume and effective salivary gland concentrations may differ ([Figure 3](#F3){ref-type="fig"}). Allowing for the concentration ranges estimated, maximum concentrations at the feeding site may range from nM to mM, and may even range from nM to μM for salivary gland concentrations such as 0.1, 0.01, or 0.001 μg for adults, nymphs, or larvae, respectively, that may be considered to be more representative of the average protein concentration. These concentrations may be an over estimation since the dynamic nature of the feeding site and the rate at which protein is secreted may never approximate these total estimated concentrations.

![Protein concentration estimates at the feeding site for larvae, nymphs and adults. Feeding sites volumes were estimated from [@B23]; [@B24]) and salivary concentrations were simulated over a 10,000-fold range assuming a maximum concentration of 10 μg in adults, 1 μg in nymphs and 0.1 μg in larvae.](fphys-10-00530-g003){#F3}

In ticks the IC~50~, *K*~D~, and *K*~i~ values range from pM--mM and falls within the concentration expected at the feeding site ([Figure 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). IC~50~ values generally tend to range from 10 nM to 10 μM ([Figure 2](#F2){ref-type="fig"}). Conversely, *K*~D~ values range from 1 nM to 1 μM, while *K*~i~ values range from 10 pM to 10 nM. The higher IC~50~ values is probably due to the use of *in vitro* assays that measure complex reactions such as platelet aggregation, blood clotting, complement or cell migration. These systems do not necessarily represent true *in vivo* conditions and may be artificial to some extent, i.e., much higher concentrations of agonists or cell numbers are needed for observation than what is found under physiological conditions. The *K*~D~ values may represent true affinities, while the *K*~i~ values are dependent on the enzyme and substrate concentrations used, and the lower pM values may be due to the availability of chromogenic and fluorogenic substrates that enable sensitive measurement of enzyme activity. In this case, some of the affinities may be overestimated.

![Ranges of IC~50~, *K*~D~, and *K*~i~ values from the tick literature. Indicated are frequency distribution curves of values obtained from [Table 1](#T1){ref-type="table"} and references therein.](fphys-10-00530-g004){#F4}

A number of tick proteins characterized have affinities, inhibition constants or IC~50~ values in the nM or pM range, which would probably be functional at the feeding site ([Figure 4](#F4){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). For some, concentrations at the feeding site may be estimated based on yields of purified inhibitor and these are generally in the same range as the affinities or higher, suggesting biological relevant concentrations at the feeding site ([Table 1](#T1){ref-type="table"}). For a number of proteins, estimates of concentrations at the feeding site is not available and the low nM to pM range of their *K*~D~, *K*~i~, or IC~50~ values is the only indication of functional relevance. A number of proteins also present extraordinary high concentration estimates at the feeding sites (\>1 M), which may indicate that these proteins may not have been completely purified at the time of their characterization, or may reflect that they derived from whole body extracts and not tick salivary glands, which may suggest that these inhibitors originate from multiple organs ([@B98],[@B99]). In many cases, the concentration of inhibitors that may occur at the feeding site has not been determined ([Table 1](#T1){ref-type="table"}). This will remain a major impediment in the assessment of functional relevance at the feeding site, since we are probably over rather than underestimating feeding site concentrations. To further consider functional relevance it is necessary to unpack the salivary gland repertoire into its functional modalities.

###### 

Tick inhibitors of host defenses considered to have relevant physiological function.

  Protein                                                                  Tick                                                                                                    Target                                                                                                                          Affinity (*K*~D~, *K*~i~, *K*~m~, IC~50~)                  Concentration (Minimum--Maximum)   References
  ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- ---------------------------------- ------------------------------------
  Apyrase                                                                  *Ixodes scapularis*                                                                                     ATP/ADP                                                                                                                         N/A                                                        Activity in saliva                 [@B208]
  Apyrase                                                                  *Ornithodoros moubata*                                                                                  ATP/ADP                                                                                                                         N/A                                                        Activity in saliva                 [@B207]
  Apyrase                                                                  *Ornithodoros kalahariensis*                                                                            ATP/ADP                                                                                                                         *K*~m~ \~ 1 mM                                             Activity in saliva 1 μM--1 mM      [@B137]; [@B148]
  Ir-CPI                                                                   *Ixodes ricinus*                                                                                        fXIIa, fXIa, Plasmin                                                                                                            *K*~D~ \~ 16--38 nM                                        Unknown                            [@B48]
  PAI                                                                      *Ixodes sinensis*                                                                                       Platelets                                                                                                                       IC~50~ \~ 250 nM                                           Unknown                            [@B132]
  Savignygrin                                                              *Ornithodoros kalahariensis*                                                                            α~IIb~β~3~                                                                                                                      IC~50~ \~ 130 nM; *K*~D~ \~ 60 nM                          55 μM--57 mM                       [@B151]; [@B156]
  Monogrin                                                                 *Argas monolakensis*                                                                                    α~IIb~β~3~                                                                                                                      IC~50~ \~ 150 nM                                           10 μM--10 mM                       [@B141]
  Variabilin                                                               *Dermacentor variabilis*                                                                                α~IIb~β~3~                                                                                                                      IC~50~ \~ 150 nM                                           2.7 μM--2.7 mM                     [@B257]
  Disagregin                                                               *Ornithodoros moubata*                                                                                  α~IIb~β~3~                                                                                                                      IC~50~ \~ 104 nM; *K*~D~ \~ 40 nM                          20 μM--20 μM                       [@B110]
  YY-39                                                                    *Ixodes scapularis*                                                                                     α~IIb~β~3~                                                                                                                      IC~50~ \~ 4--20 μM                                         Unknown                            [@B238]
  TAI                                                                      *Ornithodoros moubata*                                                                                  α~2~β~1~                                                                                                                        IC~50~ \~ 5--8 nM; *K*~D~ \~ 40 nM                         50 nM--50 μM                       [@B111]
  Moubatin                                                                 *Ornithodoros moubata*                                                                                  TXA~2~                                                                                                                          IC~50~ \~ 50 nM *K*~D~ \~ 24 nM                            1.5 μM--1.5 mM                     [@B260]; [@B160]
  TSGP2                                                                    *Ornithodoros kalahariensis*                                                                            LTB~4~                                                                                                                          *K*~D~ \~ 18 nM                                            38 μM--38 mM                       [@B149]; [@B160]
  TSGP3                                                                    *Ornithodoros kalahariensis*                                                                            TXA~2~; LTB~4~                                                                                                                  *K*~D~ \~ 5--21 nM                                         38 μM--38 mM                       [@B149]; [@B160]
  Ir-LBP                                                                   *Ixodes ricinus*                                                                                        LTB~4~                                                                                                                          *K*~D~ \~ 0.5 nM                                           Detected in saliva                 [@B18]
  TSGP4                                                                    *Ornithodoros kalahariensis*                                                                            LTC~4~                                                                                                                          *K*~D~ \< 2 nM                                             35 μM--35 mM                       [@B149]; [@B159]
  AM-33                                                                    *Argas monolakensis*                                                                                    LTC~4~                                                                                                                          *K*~D~ \~ 2 nM                                             3.5 μM--3.5 mM                     [@B143]; [@B159]
  TSGP1                                                                    *Ornithodoros kalahariensis*                                                                            Histamine Serotonin                                                                                                             *K*~D~ \< 3 nM; *K*~D~ \~ 6 nM                             32 μM--32 mM                       [@B149], [@B142]
  OP-3                                                                     *Ornithodoros parkeri*                                                                                  Histamine Serotonin                                                                                                             *K*~D~ \~ 106 nM; *K*~D~ \~ 116 nM                         Detected in SGE                    [@B67] [@B160]
  OtLip                                                                    *Ornithodoros turicata*                                                                                 Histamine                                                                                                                       Unknown                                                    Unknown                            [@B169]
  Monomine                                                                 *Argas monolakensis*                                                                                    Histamine                                                                                                                       *K*~D~ \~ 7 nM                                             29 μM--28 mM                       [@B142],[@B143]
  Monotonin                                                                *Argas monolakensis*                                                                                    Serotonin                                                                                                                       *K*~D~ \< 2 nM                                             10 μM--10 mM                       [@B142],[@B143]
  Is-14                                                                    *Ixodes scapularis*                                                                                     Histamine Serotonin                                                                                                             *K*~D~ \~ 427 nM; *K*~D~ \< 2                              Unknown                            [@B143]
  Is-15                                                                    *Ixodes scapularis*                                                                                     Histamine Serotonin                                                                                                             *K*~D~ \~ 746 nM; *K*~D~ \< 2                              Unknown                            [@B143]
  HBP1-3                                                                   *Rhipicephalus appendiculatus*                                                                          Histamine                                                                                                                       *K*~D~ \~ 1--18 nM                                         Detected in SGE                    [@B183]
  SHBP                                                                     *Dermacentor reticulatus*                                                                               Histamine Serotonin                                                                                                             *K*~D~ \~ 1--2 nM *K*~D~ \~ 0.6 nM                         Unknown                            [@B221]
  Savignin                                                                 *Ornithodoros kalahariensis*                                                                            Thrombin                                                                                                                        *K*~i~ \~ 5 pM                                             850 nM--1 mM                       [@B174]
  P5                                                                       *Hyalomma dromedarii*                                                                                   Thrombin                                                                                                                        *K*~i~ \~ 500 nM                                           30 μM--30 mM                       [@B100]
  Sculptin                                                                 *Amblyomma sculptum*                                                                                    Thrombin                                                                                                                        IC~50~ \~ 2 pM *K*~i~ \~ 18 pM;                            Unknown                            [@B103]
  Avathrin                                                                 *Amblyomma variegatum*                                                                                  Thrombin                                                                                                                        IC~50~ \~ 7 nM *K*~i~ \~ 545 pM                            Unknown                            [@B106]
  Boophilin                                                                *Rhipicephalus microplus*                                                                               Thrombin                                                                                                                        IC~50~ \~ 1 μM *K*~i~ \~ 101, 0.5--2 nM *K*~D~ \~ 116 nM   Unknown                            [@B133]; [@B233]; [@B13]
  RmS-15                                                                   *Rhipicephalus microplus*                                                                               Thrombin                                                                                                                        SI \~ 2                                                    Unknown                            [@B213]; [@B265]
  Hyalomin-1                                                               *Hyalomma rufipes*                                                                                      Thrombin                                                                                                                        *K*~i~ \~ 12 nM *K*~D~ \~ 19 nM                            Unknown                            [@B107]
  rIxscS-1E1                                                               *Ixodes scapularis*                                                                                     Thrombin                                                                                                                        SI \~ 4                                                    Unknown                            [@B97]
  Monobin                                                                  *Argas monolakensis*                                                                                    Thrombin                                                                                                                        *K*~i~ \~ 6 pM                                             400 nM--400 μM                     [@B141]
  Chimadanin                                                               *Haemaphysalis longicornis*                                                                             Thrombin                                                                                                                        IC~50~ \~ 300 nM                                           Unknown                            [@B167]
  Madanins                                                                 *Haemaphysalis longicornis*                                                                             Thrombin                                                                                                                        *K*~D~ \~ 3--4 μM; *K*~i~ \~ 31--55 nM                     Unknown                            [@B105]; [@B65]
  Variegin                                                                 *Amblyomma variegatum*                                                                                  Thrombin                                                                                                                        IC~50~ \~ 1 nM; *K*~i~ \~ 10 pM                            Unknown                            [@B113]; [@B119]
  NTI-2                                                                    *Hyalomma dromedarii*                                                                                   Thrombin                                                                                                                        *K*~i~ \~ 211 nM                                           3.8 mM--3.8 M                      [@B99]
  Americanin                                                               *Amblyomma americanum*                                                                                  Thrombin                                                                                                                        *K*~i~ \~ 0.073 nM                                         100 nM--100 μM                     [@B268]
  Saliva                                                                   *Amblyomma americanum*                                                                                  fXa; Thrombin                                                                                                                   100% I \~ 0.3 SU                                           Unknown                            [@B269]
  Ornithodorin                                                             *Ornithodoros moubata*                                                                                  Thrombin                                                                                                                        *K*~i~ \~ 1 pM                                             Unknown                            [@B249]
  Anticoagulant                                                            *Ixodes holocyclus*                                                                                     Clotting                                                                                                                        IC~50~ \~ 0.25 SGU                                         Unknown                            [@B3]
  Ixin                                                                     *Ixodes ricinus*                                                                                        Thrombin                                                                                                                        IC~50~ \~ 0.6 SGU                                          Unknown                            [@B91]
  Calcaratin                                                               *Rhipicephalus calcaratus*                                                                              Thrombin                                                                                                                        Unknown                                                    Unknown                            [@B164]
  Haemathrin                                                               *Haemaphysalis bispinosa*                                                                               Thrombin                                                                                                                        IC~50~ \~ 40 μM                                            Unknown                            [@B21]
  Microphilin                                                              *Rhipicephalus microplus*                                                                               Thrombin                                                                                                                        IC~50~ \~ 6--42 μM                                         17 μM--17 mM                       [@B37]
  BmAP                                                                     *Rhipicephalus microplus*                                                                               Thrombin                                                                                                                        IC~50~ \~ 100 nM--1 μM                                     333 nM--33 μM                      [@B92]
  NTI-1                                                                    *Hyalomma dromedarii*                                                                                   Thrombin                                                                                                                        *K*~i~ \~ 11.7 μM                                          650 μM--6.5 M                      [@B99]
  HLS2                                                                     *Haemaphysalis longicornis*                                                                             Thrombin                                                                                                                        IC~50~ \~ μM                                               Unknown                            [@B101]
  IRS-2                                                                    *Ixodes ricinus*                                                                                        Cathepsin G; Chymase                                                                                                            IC~50~ \~ 4--11 nM                                         Unknown                            [@B35]
  AamS6                                                                    *Amblyomma americanum*                                                                                  Undefined                                                                                                                       All tests μM range; no parameters                          Immunogenic                        [@B30]; [@B165]
  Penthalaris                                                              *Ixodes scapularis*                                                                                     Tissue factor pathway                                                                                                           IC~50~ \~ 100 pM                                           Unknown                            [@B69]
  Ixolaris                                                                 *Ixodes scapularis*                                                                                     Tissue factor pathway fXa                                                                                                       IC~50~ \~ pM range                                         Unknown                            [@B72]; [@B162]
  Hd_fXaI                                                                  *Hyalomma dromedarii*                                                                                   fXa                                                                                                                             *K*~i~ \~ 134 nM                                           0.3 mM--300 mM                     [@B98]
  Anticoagulant                                                            *Rhipicephalus appendiculatus*                                                                          fXa                                                                                                                             450% clotting time increase for 2 SGU                      100 nM--125 μM                     [@B131]
  TAP                                                                      *Ornithodoros moubata*                                                                                  fXa                                                                                                                             *K*~i~ \~ 0.6 nM                                           8 μM--8 mM                         [@B261]
  fXaI                                                                     *Ornithodoros kalahariensis*                                                                            fXa                                                                                                                             *K*~i~ \~ 0.8 nM                                           250 nM--250 μM                     [@B77]
  Salp14                                                                   *Ixodes scapularis*                                                                                     fXa                                                                                                                             IC~50~ \~ 150 nM                                           Immunogenic                        [@B168]
  Amblyomin-X                                                              *Amblyomma sculptum*                                                                                    fXa                                                                                                                             IC~50~ \~ 10 μM; *K*~i~ \~ 4 μM                            Unknown                            [@B17]; [@B22]
  TIX-5                                                                    *Ixodes scapularis*                                                                                     fV                                                                                                                              IC~50~ \~ 3.2 μM; all tests μM range                       Immunogenic                        [@B226], [@B225]
  Rhipilin-1                                                               *Rhipicephalus haemaphysaloides*                                                                        Elastase                                                                                                                        SI \~ 6                                                    Unknown                            [@B29]
  BmTI-A                                                                   *Rhipicephalus microplus*                                                                               Elastase; Kallikrein                                                                                                            *K*~i~ \~ 1.4 nM; *K*~i~ \~ 120 nM                         Unknown                            [@B237]
  Iris                                                                     *Ixodes ricinus*                                                                                        Elastase TNF-α                                                                                                                  IC~50~ \~ μM IC~50~ \~ 50 nM                               Unknown                            [@B128]; [@B195], [@B196]
  RsTIQ 2, 5, 7                                                            *Rhipicephalus sanguineus*                                                                              Elastase; plasmin                                                                                                               *K*~i~ \~ 1--38 nM                                         Unknown                            [@B222]
  Haemaphysalin                                                            *Haemaphysalis longicornis*                                                                             fXIIa                                                                                                                           IC~50~ \~ 50--100 nM; *K*~D~ \~ 3 nM                       Unknown                            [@B112]
  AAS19                                                                    *Amblyomma americanum*                                                                                  Plasmin; Thrombin                                                                                                               SI \~ 3--9                                                 Unknown                            [@B117]; [@B198]
  TdPI                                                                     *Rhipicephalus appendiculatus*                                                                          Tryptase                                                                                                                        *K*~i~ \< 1.5 nM                                           Unknown                            [@B186]
  Tryptogalinin                                                            *Ixodes scapularis*                                                                                     Plasmin Tryptase                                                                                                                *K*~i~ \~ 5.83 nM *K*~i~ \~ 10 pM                          Unknown                            [@B247]
  Sialostatin L                                                            *Ixodes scapularis*                                                                                     Cathepsin L                                                                                                                     IC~50~ \~ 5 nM; *K*~i~ \~ 95 pM                            Detected in saliva                 [@B122]
  Sialostatin L2                                                           *Ixodes scapularis*                                                                                     Cathepsin L                                                                                                                     IC~50~ \~ 70 pM; *K*~i~ \~ 65 pM                           Unknown                            [@B121]
  Iristatin                                                                *Ixodes ricinus*                                                                                        Cathepsin L and C                                                                                                               IC~50~ \~ 500 nM--3 μM                                     Unknown                            [@B120]
  OmC2                                                                     *Ornithodoros moubata*                                                                                  Cathepsin L and S                                                                                                               IC~50~ \~ 150 pM; *K*~i~ \~ 65 pM                          Detected in saliva                 [@B82]; [@B220]
  BrBmcys2b                                                                *Rhipicephalus microplus*                                                                               Cathepsin B and L                                                                                                               *K*~i~ \~ 1--3 nM                                          Detected in saliva                 [@B187]
  RHcyst-2                                                                 *Rhipicephalus haemaphysaloides*                                                                        Cathepsin S                                                                                                                     IC~50~ \~ 100 pM                                           Detected in saliva                 [@B258]
  TCI                                                                      *Rhipicephalus bursa*                                                                                   Carboxy-peptidase                                                                                                               *K*~i~ \~ 1--4 nM                                          150 nM--150 μM                     [@B11]
  HlTCI                                                                    *Haemaphysalis longicornis*                                                                             Carboxy-peptidase                                                                                                               IC~50~ \~ 10 μM                                            Unknown                            [@B80]
  Evasin-1                                                                 *Rhipicephalus sanguineus*                                                                              CCL3; CCL8; CCL18                                                                                                               *K*~D~ \~ 160 pM; *K*~D~ \~ 810 pM; *K*~D~ \~ 3 nM         Detected in saliva                 [@B73]
  Evasin-3                                                                 *Rhipicephalus sanguineus*                                                                              CXCL1; CXCL8                                                                                                                    *K*~D~ \~ 340 pM; *K*~D~ \~ 700 pM;                        Detected in saliva                 [@B52]
  Evasin-4                                                                 *Rhipicephalus sanguineus*                                                                              CCL1-CCL27                                                                                                                      *K*~D~ \~ 10--700 pM;                                      Detected in saliva                 [@B51]
  P1243 (AAM-02)                                                           *Amblyomma americanum*                                                                                  CCL1-CCL27                                                                                                                      *K*~D~ \~ 1--100 nM                                        Unknown                            [@B2]
  P1156                                                                    *Ixodes ricinus*                                                                                        CXCL1-8                                                                                                                         *K*~D~ \~ 3--70 nM                                         Unknown                            [@B2]
  RPU-01, RPU-02, AAM-01, AAM-02, ACA-01, ACA-02, AMA-01, ATR-02, IRI-01   *Rhipicephalus pulchellus Amblyomma americanum Amblyomma cajennense Ixodes ricinus Ixodes holocyclus*   Eotaxin-1; Eotaxin-2; Eotaxin-3; MCP-1; MCP-2; MCP-3                                                                            *K*~D~ \~ 5--1,000 nM                                      Unknown                            [@B87]
  P991, P985, P546, P974, P983, P1181, P1182, P1183, P1180, P467           *Amblyomma maculatum Amblyomma triste Amblyomma parvum Rhipicephalus pulchellus*                        CCL2, CCL3, CCL4, CCL7, CCL8, CCL11, CCL13,CCL14, CCL16, CL17, CCL18,CCL19 CCL20,CCL21, CCL22, CL23 CCL24,CCL27, CCL28, CCL25   *K*~D~ \~ 1 pM--3 μM                                       Unknown                            [@B230]
  P672                                                                     *R. pulchellus*                                                                                         CCL3, CCL8, CCL11, CCL13, CCL14, CCL16, CCL18, CCl23                                                                            *K*~D~ \~ 1--10 nM; IC50 \~ 2--6 nM                        Unknown                            [@B59]
  OMCI                                                                     *Ornithodoros moubata*                                                                                  C5 complement                                                                                                                   IC~50~ \~ 12--27 nM *K*~D~ \~ 18 nM *K*~D~ \< 100 pM       29 μM--29 mM                       [@B175]; [@B89]; [@B136]
  TSGP2                                                                    *Ornithodoros kalahariensis*                                                                            C5 complement                                                                                                                   *K*~D~ \~ 26 nM                                            38 μM--38 mM                       [@B149]; [@B160]
  TSGP3                                                                    *Ornithodoros kalahariensis*                                                                            C5 complement                                                                                                                   *K*~D~ \~ 14 nM                                            38 μM--38 μM                       [@B149]; [@B160]
  RaCI                                                                     *Rhipicephalus appendiculatus*                                                                          C5 complement                                                                                                                   IC~50~-6--21 nM                                            Unknown                            [@B108]
  Isac; Salp9; Salp20                                                      *Ixodes scapularis*                                                                                     C3 complement                                                                                                                   IC~50~ \~ 200 nM                                           Detected in saliva                 [@B248]; [@B232]; [@B243], [@B244]
  IRAC; IxAC                                                               *Ixodes ricinus*                                                                                        C3 complement                                                                                                                   IC~50~ \~ 10--50 nM                                        Unknown                            [@B43]; [@B224]; [@B42]
  HT1-12                                                                   *Ixodes holocyclus*                                                                                     Presynapse                                                                                                                      IC~50~ \~ 1--10 mM                                         Detected in saliva                 [@B31]
  Salp15                                                                   *Ixodes scapularis*                                                                                     T cell proliferation IL2 production CD4                                                                                         *K*~D~ \~ 47 nM                                            Detected in saliva                 [@B5]; [@B75]
  Longistatin                                                              *Haemaphysalis longicornis*                                                                             RAGE                                                                                                                            *K*~D~ \~ 72 nM                                            Detected in saliva                 [@B6]
  Adrenomedullin                                                           *Ornithodoros moubata*                                                                                  Vasodilation                                                                                                                    IC~50~ \~ 7 nM                                             Unknown                            [@B104]
  Ra-KLP                                                                   *Rhipicephalus appendiculatus*                                                                          maxiK channels                                                                                                                  AC~50~ \~ 1 μM                                             Unknown                            [@B185]
  Ixonnexin                                                                *Ixodes scapularis*                                                                                     Plasminogen-tPA                                                                                                                 *K*~m~ \~ 70--200 nM *K*~D~ \~ 4--19 nM                    Detected in saliva                 [@B14]
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Tick Feeding and Modulation of Host Defenses
============================================

Ticks need to modulate their vertebrate host's defense mechanisms to obtain a successful blood-meal ([@B71]). In this regard, ticks secrete numerous proteins during feeding that function as inhibitors, enzymes, or kratagonists that use a variety of mechanisms to overcome host defenses ([@B139]; [@B145]) ([Figure 5](#F5){ref-type="fig"}).

![Various mechanisms used by ticks to modulate vertebrate host defenses.](fphys-10-00530-g005){#F5}

Inhibitors That Target Enzyme Active Sites and/or Substrate-Binding Exosites
============================================================================

Various enzymes are involved in host hemostasis and many are part of enzyme cascades such as the blood clotting or complement cascade that enable efficient control as well as rapid response to injury or infection ([@B71]). Inhibitors for these cascades are found in all ticks. Inhibitors of blood-clotting enzymes generally target the active and exosites and inhibit primary enzymatic activity of thrombin, fXa, kallikrein, kallikrein-fXIIa--fXIa, fXa-TF-VIIa, plasmin, fV or carboxypeptidase B, thereby inhibiting formation or dissolution of the fibrin clot ([Table 1](#T1){ref-type="table"} including references). Inhibitors may also target enzymes that may induce platelet aggregation such as cathepsin G, or enzymes involved in inflammation such as cathepsin B, C, H, L, S, and V, chymase, elastase, and tryptase ([Table 1](#T1){ref-type="table"} and references therein). Targeting of enzyme active sites or substrate-binding exosites prevent binding of the substrate to the enzyme, thereby blocking its downstream effects. Most of these inhibitors have affinity measurements ranging from low pM to nM and for those whose concentrations could be estimated, would be present at relevant concentrations ([Table 1](#T1){ref-type="table"}).

With regard to host protein concentrations and affinities, prothrombin occurs at \~1.4 μM in plasma, although only sub μM quantities are generally converted to thrombin ([@B27]). Fibrinogen and fibrin has a low affinity site for thrombin with *K*~D~ \~ 2--5 μM and a high affinity site with *K*~D~ \~ 100 nM, while occurring at a plasma concentration of \~7.6 μM. In addition, the *K*~D~ for the thrombin platelet receptor GP1bα is \~50--200 nM ([@B1]). It is therefore not unexpected that inhibitors would have *K*~D~ values in the low nM or pM range, while also occurring at low nM to μM concentration ranges to allow efficient competition with fibrinogen. fX occur at a plasma concentration of \~170 nM, while fXa concentrations found in the clot range from 2 to 16 nM ([@B27]). These concentrations also correlate with *K*~i~ values of tick inhibitors that are in the low nM range or below ([Table 1](#T1){ref-type="table"}). Other blood clotting factors have even lower concentrations ranging from low nM to pM concentrations in plasma ([@B27]). Neutrophil derived proteases such as elastase or cathepsin G can reach concentrations of 100 nM at the site of release and is sufficient to induce platelet aggregation ([@B63]). Again, the low nM IC~50~ or *K*~D~ values for the tick inhibitors correspond with the host target concentrations, supporting functional relevance at the tick feeding site ([Table 1](#T1){ref-type="table"}). Some clotting enzyme inhibitors have *K*~i~ or IC~50~ values in the μM ranges ([Table 1](#T1){ref-type="table"}). While estimates indicate that tick proteins may achieve such high concentrations at the feeding site, it remains crucial to confirm that they actually do.

Inhibitors That Target Sites Distant From Enzyme Active Sites
=============================================================

Inhibitors may target enzymes at sites distant from the active site, thereby disrupting complex assembly and downstream activation and include inhibitors of C5 complement such as *Ornithodoros moubata* complement inhibitor (OMCI) and *Rhipicephalus appendiculatus* complement inhibitor (RaCI) ([@B175]; [@B108]). OMCI binds to the C5d, CUB, and C345c domains of C5, while RaCI binds to the MG1, MG2, and C5d domains ([@B108]). In both cases, these domains and the inhibitor binding sites are distant from C5a or the C5 convertase binding sites suggesting that these inhibitors do not directly inhibit interaction of convertases with C5, but probably inhibit rearrangement of domains within C5 that is necessary for activation to occur ([@B108]). Other complement inhibitors from soft ticks include the OMCI homologs TSGP2 and TSGP3 from *O. kalahariensis* ([@B160]). These inhibitors have *K*~D~ values in the low nM range ([Table 1](#T1){ref-type="table"}). A recent study that used site-specific immobilization of OMCI and multicycle kinetics indicated that the *K*~D~ may even be in the low pM ranges indicating that assay design can affect estimations of affinity ([@B136]). These inhibitors also show quite high expected concentrations at the feeding site, which is mostly due to their functioning as kratagonists (section below). Complement C5 occur at a concentration of \~370 nM in plasma and its activator (C3/C5 convertase) show *K*~m~ values of 5--16 nM for the classical and alternative complement pathways ([@B200], [@B201]). Therefore, even at low nM concentrations and the high concentrations of inhibitor expected at the feeding site, the tick proteins should be functionally relevant. Hard ticks also possess complement inhibitors that belong to the Isac/IRAC family ([@B248]). These inhibitors target the C3 convertase complex (C3bBbP) of the alternative pathway and dissociate this complex, preventing binding of the convertase to C3. IC~50~ values that range from 10 to 200 nM has been reported ([Table 1](#T1){ref-type="table"}). Of these inhibitors, Salp20 specifically target properdin of the C3 convertase complex and bind with a *K*~D~\~0.6 nM, which is much lower than the *K*~D~ of properdin (\>85 nM) for C3b ([@B244]). As such, these inhibitors should be functionally relevant at the feeding site although affinities for all homologs have not yet been determined. The blood-clotting inhibitor ixolaris targets the heparin-binding exosite of fXa, thereby disrupting formation of the prothrombinase complex with an IC~50~ in the pM range ([@B72]; [@B162]). It would therefore be expected to be functionally relevant.

Inhibitors That Target Receptor Ligand-Binding Sites
====================================================

Inhibitors that target cell receptors thereby blocking binding of natural ligands and receptor activation includes fibrinogen receptor (GPIIbIIIa; α~IIb~β~3~) antagonists that inhibit platelet aggregation induced by any agonist ([@B110]; [@B257]; [@B151], [@B141]; [@B238]). It has been shown that these inhibitors can also compete with bound fibrinogen to disaggregate aggregated platelets ([@B150]). Binding to the fibrinogen receptor do not seem to result in outside-in signaling by these agonists. Inhibitors that target fibrinogen receptors need to be present at high concentrations, since platelets possess high numbers of the α~IIb~β~3~ integrin on their surface (\~80,000 receptors/platelet) ([@B252]). This could result in concentrations of active receptor of \~39 nM at the feeding site. The affinity constant (*K*~D~) for fibrinogen is \~1.4 μM, while fibrinogen occur in 10-fold excess ([@B74]). It is therefore not unexpected that inhibitors would have *K*~D~ values in the nM range to bind to the receptor, while also occurring at μM concentrations to effectively compete with fibrinogen. Conversely, inhibitors with *K*~D~ or IC~50~ values above 1 μM may not be effective inhibitors.

Tick adhesion inhibitor (TAI) inhibits adhesion of platelets to collagen with an IC~50~ \~ 8 nM ([@B111]). Competitive inhibition (IC~50~ \~ 5 nM) of binding of the monoclonal antibody Gi9 to the platelet collagen receptor GPIa-IIa (α~2~β~1~) confirmed targeting of this receptor by TAI ([@B111]). The collagen receptor (GP1a/IIa) occur at low receptor numbers on platelets (800 receptors/platelet) resulting in a concentration of \~400 pM at the feeding site ([@B38]). The affinity of collagen for platelets is also \~35--90 nM ([@B109]). It is therefore not surprising that the affinity for collagen receptor antagonists may be in the low nM range, with similar low nM concentrations at the feeding site.

Longistatin binds to the V domain of the receptor for advanced glycation end products (RAGE) with a *K*~D~ \~ 72 nM, thereby inhibiting ligand-induced inflammation in tissues ([@B6]). It has been detected at the feeding site using host antibodies and would therefore presumably be present at nM concentrations ([@B9]). The concentration for RAGE is in the low pM ranges ([@B20]) and longistatin should therefore be able to saturate the receptor at nM concentrations.

Inhibitors that target receptors and upon binding induce antagonistic responses do exist. Salp15 binds to the CD4 coreceptor on T cells with a *K*~D~ \~ 47 nM and inhibits T-cell receptor ligation induced activation resulting in immunosuppression ([@B5]; [@B75]). Salp15 also interact with DC-SIGN on dendritic cells (DC) to activate the serine∖threonine kinase Raf-1. This leads to modulation of Toll-like receptor induced DC activation ([@B93]). However, in the latter case no affinity assessment was done, so it remains difficult to assess the biological relevance of this at the tick-feeding site. The CD4 coreceptor occurs at \~16--664 pM ([@B193]), and if Salp15 occur at concentrations equal or above its *K*~D~ for the CD4 coreceptor should saturate the receptor and will be biologically relevant. The neurotoxins from *Ixodes holocyclus* are presumed to target and inhibit presynaptic P/Q-type voltage gated calcium channels ([@B31]). Recombinant holocyclotoxins have IC~50~ values ranging from 5 to 12 μM, which seem to be orders of magnitude higher than the concentrations present in saliva ([@B31]), suggesting that a discrepancy still exist between the identified toxins and crude salivary composition ([@B192]).

Inhibitors That Target Soluble Protein Agonists
===============================================

A number of soluble host protein agonists exist that play a role in inflammation and immunity. These generally bind to receptors on leukocytes to activate cellular responses and cellular migration and are collectively known as cytokines or chemokines ([@B234]). Leukocytes include eosinophils, mast cells, monocytes, neutrophils and natural killer cells that migrate along chemokine concentration gradients caused by release of chemokines from sites of infection or inflammation ([@B163]). A large number of chemokines exist that have specificities for different cell types. Chemokines are classified based on their conserved disulphide bond patterns. C chemokines possess a single disulphide bond and consist of two chemokines (XCL1 and XCL2). CC chemokines (β-chemokines) possess two disulphide bonds, with adjacent cysteines near the N-terminal and consist of 28 chemokines (CCL1--CCL28), described thus far. CXC chemokines (α-chemokines) possess two disulphide bonds with the adjacent cysteines near the N-terminal separated by a single amino acid and consist of 17 chemokines (CXCL1--CXCL17), described to date. A number of inhibitors from ticks that interact directly with these soluble agonists and prevent binding to their receptors have been described and are known as the evasins ([@B73]; [@B52]). It has been shown that evasins can bind to a wide array of cytokines or chemokines ([Table 1](#T1){ref-type="table"}). Their *K*~D~ values range from low pM to nM.

In the case of chemokines where leukocytes respond to concentration gradients for directional chemotaxis, the measured gradients suggest that these may range across low pM to several hundred nM ([@B163]). Naturally formed gradients depend on various factors that will influence the concentration gradient, notably, the type of cell secreting the chemokine, the amount secreted that depend on environmental cues, the presence of flow-induced shear stress and interaction of the chemokines with the extracellular matrix ([@B163]). Depending on the *K*~D~ of the evasins (low nM), chemotaxis may only be efficiently inhibited somewhere along the concentration gradient and not across the whole range, especially since competition of evasins for different chemokines might occur.

Enzymes That Target Matrices or Matrix Components
=================================================

Ticks feed from a feeding cavity where blood pools ([@B240]). The feeding site needs to be remodeled to form this cavity ([@B264]). Ticks may secrete a variety of enzymes that will enable such remodeling. This includes hyaluronidase that targets hyaluronic acid, a major component of the extracellular matrix ([@B170]). Salivary transcriptomes also indicate that an abundant class of enzymes are the metalloproteases ([@B145]). While their role in feeding site remodeling has not been established beyond doubt, the general assumption is that these enzymes would play a role in remodeling ([@B140]; [@B264]). Other metalloproteases that has been identified with a defined function include fibrin(ogen)ase activity that remove fibrinogen, both substrate for thrombin or platelet aggregation, or fibrin that forms the blood clot ([@B68]). Longistatin, a small EF-hand protein can hydrolyze α, β, and γ chains of fibrinogen, activates plasminogen to plasmin, degrade fibrin and dissolve fibrin clots ([@B7], [@B8]). Other enzymes that may target the fibrin clot without a direct interaction include plasminogen activators such as enolase that promote degradation of the fibrin clot via activation of the host enzyme plasminogen to plasmin ([@B54]; [@B266]). A serine protease that potentially activates protein C, a potent anticoagulant has also been identified in saliva of *Ixodes scapularis* ([@B191]). For these "activating" enzymes the physiological effective concentrations in saliva may be low (pM--nM ranges) and detection of function in saliva (not salivary gland extract) may be enough to infer functional significance given their amplification/catalyzing nature.

Enzymes That Perform Scavenging Functions
=========================================

Some enzymes may perform scavenging functions by targeting bioactive molecules and catalyzing chemical reactions that inactivate or remove these molecules. This may prevent activation of receptors, or induce antagonistic responses in receptors by removal of activating ligand. In ticks, the enzyme apyrase (ATP-diphosphohydrolase; EC 3.6.2.5) hydrolyse ATP that function in inflammation ([@B62]), as well as ADP that induce platelet aggregation ([@B208], [@B207]; [@B147], [@B141]). Apyrase was able to disaggregate platelets aggregated by ADP and caused platelet shape change from an activated spherical back to discoid form ([@B148], [@B144]), suggesting that bound ADP could be scavenged from its platelet receptor. Apyrase activity has been found in saliva or salivary glands of most ticks studied and have been assigned to the 5′-nucleotidase family ([@B236]). Family members have been found in all tick transcriptomes studied to date ([@B145]). Kinetic parameters from purified apyrase indicated a *K*~m~ \~ 1 mM for ATP and ADP and high turnover number (10^6^ s^-1^) and *K*~cat~/*K*~m~ ratio (10^9^ M^-1^s^-1^) ([@B148]). These numbers indicate a highly efficient enzyme that would rapidly hydrolyze high local concentrations of ADP or ATP. Given the relatively high concentration of apyrase found in tick salivary glands ([@B148]), it would probably also be functionally relevant. Another enzyme found in ticks that perform scavenging functions is a metallo dipeptidyl carboxypeptidase responsible for salivary kininase activity and breakdown of anaphylatoxin and bradykinin, involved in inflammation, pain and vasoconstriction ([@B209]; [@B205]; [@B16]). In all cases of "scavenging" enzymes, the enzymes need to be able to rapidly remove host-derived agonist to levels below their functional ranges.

Kratagonists That Perform Scavenging Functions
==============================================

Kratagonists are related to "scavenging" enzymatic functions, by scavenging or mopping up of bioactive molecules, but without chemically changing their structures. Kratagonists may have similar functional activity as "scavenging" enzymes, such as preventing activation of receptors by ligands, or competitive removal of ligand from receptors causing an antagonistic response ([@B203]; [@B4]). The term kratagonist was recently coined to describe the abundant proteins found in saliva of most hematophagous organisms that function in a scavenging capacity ([@B203]). The name derives from the Greek "to arrest or to seize" and was appropriately proposed independently by the Greek compatriots Babis Savakis and Michalis Kotsyfakis ([@B203]). Recently the etymology of the name was redefined to indicate "hold" or "grab/capture" and "agonist" ([@B4]; [@B10]). In ticks a large number of kratagonists have been described, that all belong to the lipocalin family. Lipocalin structure is composed of an eight stranded anti-parallel β-barrel closed off at one end by an N-terminal 3~10~-helix, with a C-terminal α-helix anchored to the side of the barrel by disulphide bonds. This gives lipocalins the distinct appearance of a cup with an open end, where ligands can access the cup and bind in the cavity inside the barrel. Specificity is conferred by residues inside the barrel, as well as four loops that allow access to the barrel ([@B66]). The original name of lipocalin was assigned to "extracellular proteins capable of enclosing lipophiles within their structure to minimize solvent contact" ([@B189]). Subsequently, lipocalins were defined based on conserved sequence or structural motifs ([@B66]). Scavenging functions performed by tick lipocalins include scavenging of histamine and serotonin ([@B183]; [@B221]; [@B142]; [@B169]), leukotriene B4 ([@B18]; [@B160]; [@B217]), leukotriene C4 ([@B159]), thromboxane A2 ([@B160]), and cholesterol ([@B194]; [@B215]).

In the case of small chemical agonists that are scavenged by either enzymes or kratagonists, the concentrations at which they activate their respective receptors are important. Platelets secrete ADP and ATP at 3--7 μM concentrations, which are also the concentration necessary for primary and secondary aggregation ([@B182]). Apyrase from ticks has been shown to effectively inhibit platelet aggregation at these activator concentrations, at enzyme concentrations well below the expected secretory levels ([@B148]). Basophils and mast cells may secrete histamine to attain local concentrations of 20 μM in the skin that can lead to inflammatory responses when histamine binds to its receptors with *K*~D~ \~ 10 nM--30 μM ([@B190]; [@B134]). Serotonin is secreted by platelets at local concentrations of \~5 μM where it can cause vasoconstriction and platelet aggregation by binding to various serotonin receptors with *K*~i~ \~ 10 nM--1 μM ([@B259]). The very high concentrations of biogenic amine binding kratagonists at the feeding site (μM--mM) and their low affinities (low nM) indicate that they will be biologically relevant at the feeding site ([Table 1](#T1){ref-type="table"}).

Leukotriene B~4~ secreted by neutrophils may reach high concentrations at the site of neutrophil release (\~950 nM) ([@B129]). The affinity of LTB~4~ for its neutrophil receptor BLT1 ranges from 0.1 to 2 nM ([@B267]). Again, the low affinities observed for the LTB~4~ scavengers and their high concentrations (μM) at the feeding sites would make them relevant competitors at the feeding site.

Cysteinyl leukotrienes can only be detected in plasma during inflammatory reactions such as asthma attacks and then occur at concentrations of \~100--765 pM ([@B223]). It has been shown to cause vasoconstriction and vasopermeability at a concentration of \~100 nM, and bind with affinities from 5 to 35 nM to its receptors ([@B58]; [@B123]; [@B78]; [@B197]). Scavengers of LTC~4~ and LTD~4~ have *K*~D~ values below 2 nM and also occur at μM concentrations ([Table 1](#T1){ref-type="table"}). It is therefore also expected that they would be physiologically relevant during feeding.

Thromboxane A~2~ is released from platelets at concentrations of 11--35 nM, which is capable of inducing platelet aggregation and bind to platelet receptors with *K*~D~ \~ 4 nM ([@B85]; [@B57]). The high concentrations of the TXA~2~ kratagonists at the feeding site (μM--mM) and their low affinities (low nM) suggest that they would be able to neutralize TXA~2~ binding to its receptor during feeding ([Table 1](#T1){ref-type="table"}).

Activators of Host Regulatory Systems
=====================================

The majority of tick host modulatory mechanisms described so far comprise inhibitors. However, activators may also play important roles since these may target the natural regulatory feedback systems of host hemostasis. Plasminogen activators that result in degradation of the fibrin clot have already been discussed. Recently, a small peptide named ixonnexin that belongs to the basic tail family was described that act by promoting interaction of plasminogen and tissue plasminogen activator (tPA) by forming a enzymatically productive ternary complex that forms plasmin to promote fibrinolysis ([@B14]). Ixonnexin interacts with both plasminogen and tPA with similar *K*~D~ values (4--20 nM). Such an activator would need to be present at similar or higher concentrations than the target enzymes to be functionally relevant. In the case of ixonnexin, plasminogen and tPA occur at plasma concentrations of \~2 μM and 100 pM, respectively ([@B135]; [@B14]). While no exact concentration has been established for ixonnexin, it has been estimated to occur at high concentrations in saliva ([@B14]). It has also been suggested that all basic tail proteins may perform this function, including the fXa inhibitor Salp14, since this family in which the C-terminal is rich in basic amino acids such as lysine and arginine mimics the C-terminal lysine present in fibrin that serves as recognition site for plasminogen and tPA lysine binding sites ([@B14]).

The adrenomedullins are a special case of tick-derived inhibitors that bind to host calcitonin-receptor-like receptor and receptor activity-modifying protein receptor complexes to cause vasodilation ([@B104]). These inhibitors have not converged to mimic host adrenomedullin, but have been acquired via horizontal gene transfer from a mammalian host ([@B104]). At systemic concentrations of \~7 nM it reduced blood pressure by almost 50% ([Table 1](#T1){ref-type="table"}). It may therefore be assumed that secretion of such low quantities during feeding may result in local vasodilatory effects. However, it's presence in saliva at functional concentrations still needs to be confirmed.

An activator of MaxiK channels have been described in *R. appendiculatus*, where it presumably play a role in regulation of blood vessel tonus and blood flow ([@B185]). It invoked a half maximal response in MaxiK channels at 1 μM. Its functionality at the feeding site remains to be resolved.

Non-protein Agonists and Inhibitors
===================================

Ticks may also secrete non-protein agonists that could affect the host's defense mechanisms. As such, ixodid ticks secrete prostaglandin E2 (PGE2), a potent vasodilator, at \~40--500 ng/ml saliva ([@B208], [@B204]; [@B102]). Concentrations of PGE2 may range from 79 nM to 994 μM in adults at the feeding site, which would be pharmacologically active, since the *K*~D~ of the PGE2 receptor is \~0.7 nM ([@B44]). Another non-protein mechanism for modulating host inflammatory and pain sensing responses was recently reported that involved secretion of saliva-specific microRNAs that was detected in salivary exosomes using next-generation sequencing ([@B84]; [@B83]). The efficiency of exosomal miRNA will depend on the concentrations of exosomes in saliva, the specificity of the exosomes for specific cell types and the concentration of miRNA inside the exosomes ([@B96]). As yet, the functional relevance of saliva-derived exosomal miRNA still needs to be confirmed, with their kinetics of inhibition resolved, since the question remains whether a single exosome would only target a single lymphocyte or epithelial cell, in which case the effectiveness of inhibition would be determined by the number of cells that can be neutralized at the feeding site. It would, however, add another complex repertoire to the ticks expanding modulatory mechanisms.

Strategies to Circumvent the Affinity/Equilibrium Barrier
=========================================================

It is evident that the majority of tick proteins thus far characterized would have physiological functionality at the feeding site ([Figure 3](#F3){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). However, expression and secretion of high concentrations of secretory proteins via the salivary secretory granules may be restricted to very few proteins given physical constraints of granule packaging ([@B155]). The dynamic nature of the feeding site may also make the actual concentrations of tick proteins present at any given moment much more haphazard than expected. The concentrations at the feeding site may very well be 100--10,000-fold lower than estimated, in which case concentrations may drop to pM--nM for most proteins, which may be below the *K*~D~ values for many proteins. To address this, ticks may employ various alternative strategies that allow adequate expression and optimal use of secreted proteins at the feeding site that allow ticks to circumvent or eliminate the problems posed by an equilibrium system ([Figure 6](#F6){ref-type="fig"}). The next section discusses such strategies in more detail.

![Strategies to circumvent the equilibrium barrier. Ticks can use various strategies to increase local concentrations at the feeding site to satisfy equilibrium binding conditions.](fphys-10-00530-g006){#F6}

Redundancy as Means to Control Complexity and Chaos
---------------------------------------------------

The host's defense systems such as the clotting, platelet aggregation, complement and inflammatory cascades are part of one big redundant integrated feedback system that allows rapid response as well as control of the system ([@B49]; [@B50]; [@B263]). It has been argued that this redundancy is mimicked in the complexity of functions observed in the salivary glands of blood-feeding arthropods ([@B206]). Conversely, it has been argued that the complexity observed in the functional salivary repertoire of ticks is due to a highly optimized system of defense shaped by evolution ([@B178]). However, redundancy may serve the purpose of dealing with a highly dynamic and chaotic system, as may be seen at the feeding site, which is in constant flux with ever changing concentrations of target and inhibitor molecules. Targeting of many different host proteins at once, even if not at optimal concentrations, may disrupt a redundant system enough to allow successful feeding. In this environment no protein needs to be 100% effective, but only good enough to get the job done. This may allow non-optimal proteins to function at the feeding site, or be maintained while evolving more optimized functions as postulated in the playground hypothesis of neutral evolution ([@B146]). The question then becomes a matter of how much inhibition of the host's defense systems would be necessary to ensure successful feeding. In this regard, three observations could be made: firstly, that inefficient inhibition was surely a given during the early stages of adaptation to a blood-feeding lifestyle since protein functions were still optimized by natural selection. Secondly, since ticks had to switch hosts throughout their evolution, we have no evidence that ticks are not still adapting to new hosts, and functions that seem to be only partially effective may indeed still be optimized in future through natural selection. Thirdly, given the relatively high concentrations that may be obtained at the feeding site, even if proteins may only be partially effective, may allow for selection of these non-optimal functions to improve efficiency, again supporting a neutral evolution of function hypothesis ([@B146]). These arguments should, however, not serve as a *carte blanche* to support every claim of functional significance in blood-feeding, since the contribution of salivary derived proteins to species fitness has not been elucidated yet or even proven beyond doubt.

Fast Feeding, Storage and Secretion of a Large Bolus of Salivary Proteins
-------------------------------------------------------------------------

Soft ticks feed within minutes to hours to repletion, drop off, digest the blood meal slowly over the course of weeks to months, lay a small egg batch and can then feed several times more using the same pattern ([@B154]). During fast feeding most salivary proteins may be secreted in the course of 10--30 min and will be replenished within several days after feeding. Secretory proteins are stored in large granules up to 10 μM in diameter that effectively fill the salivary gland cells to their maximum extent ([@B155]; [@B158]). The protein profiles of soft tick SGE attest to this, since protein spectra rarely show the presence of genomic DNA, in contrast to SGE from hard ticks that predominantly show genomic DNA/RNA, while the protein peak and concentration is obscured ([Figure 7](#F7){ref-type="fig"}). This strategy from soft ticks allows concentrations of proteins that can overcome relatively high equilibrium dissociation constants by sheer concentration effects alone. Hard ticks utilize this strategy to some extent, since different salivary gland cells are filled with secretory granules over the course of the feeding period that can last several days to weeks ([@B19]). However, the amount of protein found in crude salivary gland extract rarely exceeds the concentrations of genomic DNA and is generally less than what would be observed for soft ticks ([Figure 7](#F7){ref-type="fig"}), and may range from 5 to 60 μg total soluble protein over the course of feeding for a small tick such as *R. appendiculatus* ([@B255]). Similarly, concentrations in pilocarpine-induced salivary secretions in hard ticks are generally lower than soft ticks, with soft ticks attaining \~20--40 mg/ml and hard ticks ranging from 700 to 60 μg/ml over the course of feeding ([@B95]; [@B202]; [@B207]; [@B53]; [@B31]).

![The absorbance spectra of salivary gland extracts (SGE) from hard and soft ticks. The top graph shows the spectrum of SGE of 4 glands from *Amblyomma hebraeum* suspended in 100 μl water. Based on the 280 nm absorbance a single gland would have a soluble protein concentration of \~128 μg. Bradford determination indicated a concentration closer to \~60 μg/gland. The bottom graph shows the spectrum of SGE of 42 glands from *Ornithodoros phacochoerus* suspended in 500 μl water. Based on the 280 nm absorbance a single gland would have a soluble protein concentration of \~127 μg. Bradford determination indicated a concentration of \~125 μg/gland. These absorbance spectra are representative of hard and soft tick SGE in general.](fphys-10-00530-g007){#F7}

Communal Feeding to Increase Local Concentrations at the Feeding Site
---------------------------------------------------------------------

Hard ticks feed for several days to weeks and mating on the host (or off the host for some *Ixodes* species) during the slow pre-feeding phase is required before the rapid engorgement phase can occur ([@B118]). To allow mate finding, males secrete attraction-aggregation-attachment pheromones that result in ticks clustering and co-feeding at the same feeding site ([@B235]). In a similar manner, specific tick species generally have preference sites of attachment on the host, presumably due to host environmental cues. While males do not engorge or take a significant blood meal, they do attach and secrete salivary components into the communal feeding site that apparently assist females in blood meal acquisition ([@B256], [@B254]). Creation of a communal locality where all ticks contribute to the localized but systemic feeding site may result in combined concentrations that overcome affinity restricted barriers.

Gene Dosage and Cumulative Contributions From Multigene Families
----------------------------------------------------------------

Proteins may be maintained as gene duplicates to allow high level expression from each family member ([@B146]). While each member may by itself completely inhibit host functions, even partial inhibition by each gene duplicate can result in complete inhibition. This is a relatively simple example of the gene dosage effect that has been observed for fibrinogen receptor antagonists ([@B152], [@B141]) and LTB~4~ scavengers ([@B153]; [@B160]). It has been proposed that multigene families express different antigenic variable family members at low concentration levels to escape the immune system, the varying epitope hypothesis ([@B42]; [@B33]). In this scenario, the low-level expressed proteins cumulatively target the same receptor to attain a combined concentration that would allow receptor saturation and inhibition. This may be possible, even if expressed at concentrations well below the equilibrium dissociation constant, since the inhibitory effects may be summed if the inhibitors act in a mutually exclusive manner (1:1 receptor-ligand binding with no synergistic effects) ([@B36]). A cumulative effect was recently shown for the holocyclotoxins from the paralysis tick, *Ixodes holocyclus*, where at least 19 holocyclotoxin genes were expressed at low levels that showed a cumulative paralysis effect when combined ([@B212]). It should be noted that while immune evasion was proposed as reason for the multiplicity of gene family members, low level expression of multiple genes to attain a cumulative threshold concentration that allows effective inhibition may also be possible and may fit with the overall neutral evolution of tick salivary gland proteins previously proposed ([@B146]). Low-level expression may in this scenario also be a function of the constitutive differential expression observed in hard ticks, where the extreme high expression levels observed in soft ticks due to accumulation in granules may not be attainable. Even so, it remains to be quantitatively proven that cumulative contributions to attain a threshold concentration occur at the feeding site.

Increasing Concentration at the Feeding Site
--------------------------------------------

The vertebrate host uses localized cues and responses to maintain and regulate haemostasis. As such, wounds or breakdown in system integrity are detected by exposure of localized collagen or other extracellular matrix components, activation of platelets and exposure of procoagulant platelet surfaces, initiation of blood-clotting and the complement cascade on activated platelet surfaces ([@B49]; [@B50]; [@B263]). In a similar manner, targeting of tick-derived bioactive molecules to activated surfaces, whether tick or host surfaces can increase local concentrations and prevent loss or dilution of components via blood meal ingestion or systemic diffusion. Salivary proteins have been found in tick cement where they presumably function as inhibitors of host defenses, or to prevent recognition of cement as a foreign or activation surface for host defenses ([@B26]). Proteins such as apyrase have asymmetric charged surfaces ([@B236]), suggesting that these would be attracted to activated negatively charged platelet membranes. Other tick proteins has been shown to interact with membranes or have higher inhibitory activity in the presence of membranes, suggesting that these proteins may be concentrated on activated membrane surfaces at the feeding site ([@B60]; [@B225]). Some Kunitz-domain inhibitors such as ixolaris have long carboxy-termini rich in serine and threonine residues that can be the site of glycosylation ([@B72]). These would create mucin tails that would be sticky and allow concentration on the walls of the feeding cavity preventing removal and increasing concentration ([@B71]). This may be a general strategy for glycosylated tick proteins ([@B245]).

Increasing Effective Concentration Using Multiple Binding Sites or Multiple Functions
-------------------------------------------------------------------------------------

In the case of some tick lipocalins their effective concentration is increased by possessing two independent binding sites for histamine or one for histamine and one for serotonin ([@B184]; [@B221]; [@B142]). This increase their capacity for scavenging twofold. Another variation on this may be proteins that can potentially target many independent ligands or targets and may therefore have multiple functions. While this certainly expands the potential of proteins to work within a complex redundant environment, the most effective of these would be proteins that have independent function and mechanisms. For example, targeting of complement C5 and LTB~4~ allows OMCI and its homologs to inhibit both complement and LTB~4~ mediated inflammation at the same time ([@B175]; [@B160]; [@B217]). In this case, both functions target the two key non-redundant mediators of neutrophil recruitment during inflammation that seems to be intricately linked ([@B219]). This is a remarkable convergence of function in a single protein ([@B146]). On the other hand, if the functional mechanisms are not independent, i.e., use the same site for ligand binding or the same protein surface to target different proteins, competition between targets will effectively lower the concentration of available inhibitor, thereby impacting its functionality. This may be seen for moubatin and its homologs that bind both LTB~4~ and TXA~2~ within the same lipocalin cavity at similar affinities ([@B160]). If both LTB~4~ and TXA~2~ are present at similar concentrations, the effective scavenging capability may be halved. One way to compensate for this may be multiple proteins or very high concentrations at the feeding site as observed for moubatin, TSGP2 and TSGP3. The same problem would face many of the enzyme inhibitors that can inhibit two or more enzymes from a specific class such as the cystatins, where the presence of many different host enzymes at the feeding site would lead to competition with the tick inhibitors. Similarly, the evasins can bind to many chemokines with similar affinities that may lead to competition of evasins for different chemokines, thereby reducing their effectivity.

Suicide Inhibitors
------------------

Inhibitors that bind in a 1:1 manner to their target enzymes, and then serve as substrate, resulting in the formation of a covalent enzyme-inhibitor complex, circumvent the equilibrium dissociation problem completely. Their initial affinities need only to be high enough for the enzyme to catalyze its reaction and form the covalent complex to result in permanent inhibition. In ticks, such inhibitors are found in the serpins that target various enzymes of the clotting cascade ([@B34]). Serpins form covalent complexes with their respective serine proteases after cleavage ([@B262]).

Differential Expression
-----------------------

Ixodid ticks express different proteins at different periods during feeding ([@B161]; [@B183]; [@B253]; [@B116]; [@B188]). Possible reasons proposed for this include antigenic variation to escape the immune system ([@B33]), or responses to changes at the feeding site such as wound healing ([@B70]). Differential expression may also occur as salivary gland morphology changes during the course of feeding and different cell types play different roles in the feeding process ([@B19]). As such, differential expression may allow increased concentration spikes of proteins in specific feeding windows.

Minimizing Feeding Site Volume
------------------------------

Comparison of adult, nymphal, and larval concentrations at the feeding site indicates that the relative concentrations remain constant between the various life stages even though salivary gland concentrations may differ several fold ([Figure 3](#F3){ref-type="fig"}). This is mostly due to the differences observed in feeding cavity size that scale relative to the life stage and tick size. If this observation holds for all tick species it would imply that smaller ticks compensate by creating smaller feeding cavities. Feeding cavity size may then be related to protein concentration secreted during feeding.

Smaller Proteins Allow Higher Molar Concentrations
--------------------------------------------------

The majority of secretory salivary proteins in ticks have low molecular masses below 25 kDa. This include the majority of highly abundant protein families such as the basic tail secretory, Kunitz-BPTI and lipocalin families ([@B143], [@B145]; [@B139]). Lower molecular masses allow higher relative molar concentrations at the feeding site, which could result in an up to a 10-fold difference between a 5 and 50 kDa protein ([Figure 3](#F3){ref-type="fig"}).

Functional Relevance and Mechanism
==================================

Understanding the mechanism of action (how a given protein works) is important in accessing functional relevance. As example, the case of moubatin may be considered. Originally moubatin was identified as a specific inhibitor of collagen-induced platelet aggregation with an IC~50~ \~ 50 nM, that did not affect ADP, arachidonic acid, thrombin, ristocetin, or calcium ionophore A23187 induced platelet aggregation ([@B260]). Subsequently, recombinant moubatin was shown to inhibit collagen-induced platelet aggregation with IC~50~ \~ 100 nM but did not inhibit adhesion to collagen ([@B114]). At high concentrations (5.8 μM) of moubatin and low concentrations of ADP (2 μM) 40% inhibition of ADP-induced platelet aggregation was observed, suggesting that the cyclooxygenase pathway may be targeted. It was also shown that moubatin at these high concentrations could inhibit the TXA~2~ mimetic U46619 and competed with the TXA~2~ receptor antagonist SQ29548 for binding to platelet membranes with IC~50~ \~ 10 μM ([@B114]). The leech inhibitor LAPP did not compete with SQ29548 binding to platelets, indicating that different receptors were targeted. Moubatin also did not inhibit binding of the monoclonal antibody Gi9 that inhibited adhesion to collagen and interacts with integrin α~2~β~1~, the proposed receptor for adhesion to collagen. At the time, moubatin did not share sequence homology with any inhibitor of collagen-induced platelet aggregation or with collagen, and did not contain the RGD motif important in integrin recognition. From the complex data above it was suggested that moubatin might be a TXA~2~ receptor antagonist ([@B114]). Subsequently, it was shown that moubatin's mechanism of collagen-induced platelet aggregation is exclusively via scavenging of TXA~2~ with *K*~D~ \~ 20 nM, by gain and loss of function mutations in TSGP2 and TSGP3, respectively, two closely related homologs ([@B160]). In retrospect, it may be considered that the only inhibitory paradigms at the time were interaction with either collagen or specific platelet receptors and that the kratagonist paradigm as formulated recently did not exist. Interpreting the moubatin results from the previous paradigms may have been logical, even if the high IC~50~ observed for SQ29548 should have raised flags. It may now be suggested that moubatin was scavenging SQ29548 (a TXA~2~ mimetic), albeit with low affinity and did not compete for the receptor. Several lines of evidence converged on moubatin as scavenger of TXA~2~: the evidence that moubatin belonged to the lipocalin family ([@B183]; [@B153]); the fact that lipocalins are highly abundant in salivary glands and that abundant proteins generally act as scavengers, i.e., the kratagonist paradigm ([@B149], [@B153]; [@B154],[@B155]; [@B28]); the inhibitory effect of moubatin on the TXA~2~ mimetic U46619 ([@B114]), and the observation that a closely related protein, OMCI bound ricinoleic acid, suggesting that moubatin may bind prostaglandins and thromboxanes ([@B216]). The gain of function mutation in TSGP2 of R85G and a similar complete loss of function for TSGP3 with the mutation G85R, allowed unambiguous confirmation of functional relevance as TXA~2~ scavengers ([@B160]). It not only highlighted the reductionist paradigm in elucidation of function, but also showed how elucidation of mechanism may inform on which function is considered relevant. As such, moubatin is an inhibitor of collagen-induced platelet aggregation, but perform this function by scavenging the secondary agonist TXA~2~. Its mechanism is primarily as kratagonist and not as receptor or ligand neutralizing inhibitor. Once mechanism is clarified the parameters necessary to assess functional significance can be better defined. In this case, that any homolog has to bind TXA~2~ in the low nM range, be present at high concentrations and possess the R85G substitution to be functionally relevant.

Systems Biology, Bioinformatics and Functional Relevance
========================================================

While the majority of functions found in ticks may be assigned functional significance ([Table 1](#T1){ref-type="table"}), enough reports in the literature indicate that caution should be exercised when evaluating functional relevance. This is compounded by advances in technology that allow systems approaches to the analysis of salivary gland protein dynamics and bioinformatics that allows functional analysis *in silico*. As such, recent advances in technology, both in next-generation transcriptome sequencing and proteomics, has allowed an unprecedented view of salivary gland dynamics from a systems perspective ([@B227]; [@B32]; [@B145]; [@B116]). This has indicated how ticks differentially up- or down-regulate proteins during various time intervals in feeding, which suggest that ticks actively respond to the feeding environment, reflecting a fine tuned adaptation to the hosts defense mechanisms. While the systems paradigm clearly show how dynamic expression may be in ticks, inferences regarding function rests on inference by homology or annotation. For example, a recent excellent proteomic study followed the expression profile of *I. scapularis* sampled every 24 h until detachment and indicated differential expression for a large number of lipocalins annotated as histamine-binding proteins ([@B116]). The discussion focused on the functionality of lipocalins as histamine scavengers and how the data would support tick responses to host immunity and feeding. Interestingly, a functional study into biogenic amine binding lipocalins that specifically targeted *I. scapularis* lipocalins with biogenic amine binding motifs, failed to find any histamine-binding lipocalins, but only identified serotonin-binding lipocalins with a single binding site ([@B142]). While this does not exclude the possibility that histamine-binding lipocalins exist in *Ixodes* ticks, the results thus far do not support it. Similarly, bioinformatic analysis predicted high affinity binding of histamine and serotonin in lipocalins from *Ixodes ricinus*, for which none of the critical residues involved in biogenic amine binding was conserved ([@B246]). Molecular docking also recently predicted nM affinities for cystatins from *Ixodes persulcatus* without experimental verification of affinities or target enzymes ([@B199]). While such bioinformatic and systems approaches can certainly direct research to proteins of interest, the data should be used with caution to infer functional relevance, especially if the possibility exists that some of these proteins may be only transiently expressed or at concentrations too low for functionality. For systems biology to come of age, we need accurate dissection of the feeding site in real-time to quantify fluxes in protein concentration while performing quality control with validated functions.

Is Functional Relevance Relevant?
=================================

It may be considered whether it really matters whether a measured function is relevant during feeding, given the emerging recognition that all proteins may be moonlighting to some extent. From this perspective, any function present in tick saliva should be relevant at some level and our goal for the next few decades would be to assign functions to salivary proteins, whether relevant or not. A more comprehensive understanding would later emerge once we have gathered enough data to truly assess relevance. This position is appealing since it buys some time for dubious functions. It is, however, also a philosophical "everything goes" viewpoint ([@B64]), that makes distinguishing important from trivial function very difficult. The same issue has been raised with regard to whether all ticks are venomous, or whether only some ticks secrete toxins that may cause the various well recognized forms of tick paralysis and toxicoses ([@B192]). By treating all ticks as venomous, the meaning of toxicity is obscured. Similarly, by treating all functions in saliva as relevant at the feeding site, even if their functional parameters suggest that they would not be relevant, may obscure those central in the feeding process from peripheral functions.

Functional Relevance From a Practical Perspective
=================================================

The use of tick salivary proteins as therapeutic agents within a clinical or pharmaceutical setting remains an important and promising goal ([@B138]). From this perspective any function determined for a protein need not be functionally relevant at the tick feeding site, as long as the specific parameters for use has been determined that would allow it to function under clinical or therapeutic controlled conditions. For example, the half-life of OMCI could be improved \>50-fold by PASylation, making it more relevant for clinical use ([@B125]). In a similar vein, anti-tick vaccines may be developed against proteins with unknown functions or even irrelevant function, as long as the vaccine shows efficacy, as for example for hidden antigens ([@B179]). On the other hand, development of vaccines against exposed antigens may work better if antigens with real functional significance at the feeding site can be defined, their mechanism of action elucidated and this information used to rationally design target strategies that would neutralize function at the feeding site effectively.

Conclusion
==========

Functional relevance is determined by the concentration of tick proteins at the feeding site as well as their affinity for their respective host targets. The current review showed that the majority of proteins found in tick saliva or salivary glands thus far characterized will be functional at the tick feeding site. It was also shown how ticks may circumvent the problems presented by an equilibrium system. Even so, inferring functional relevance without estimating concentration or affinity at the feeding site remains a risky endeavor. Future aims in salivary gland biology should focus on quantification of protein concentration secreted during feeding as well as in the actual feeding site. This should provide more accurate estimates of functional relevance.
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